FDA Expands Approval of Focused Ultrasound for Parkinson’s
Our focused ultrasound research has paved the way for the technology to help more patients with Parkinson's.
Author: Josh Barney (Page 25)
The Potential Impact of the New COVID Pills
Our Patrick Jackson, MD, an infectious disease expert, is feeling very optimistic. Read why and learn about how the forthcoming drugs work.
Antibody Cocktail Offers Long-Lasting COVID-19 Protection
A new announcement from Regeneron Pharmaceuticals could be good news for the immunocompromised.
Amy Mathers: Innovator of the Year
Dr. Mathers has done heroic work throughout the pandemic, benefiting not just UVA but hospitals around the state.
More Good News on Fluvoxamine for COVID-19
A new study from Brazil adds to the evidence that a cheap, generic antidepressant can help prevent severe COVID-19.
Who Can Access COVID-19 Clinical Trials?
Many Americans would have to travel an hour or more to participate in a trial testing a new treatment for COVID-19.